Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Stryker has acquired AVS, a medical devices business in the United States, for up to $835M. AVS develops and supplies medical devices used in clinical care, supporting Stryker’s broader healthcare product portfolio and strengthening its medical devices acquisition strategy. Stryker acquisitions in healthcare M&A focus on expanding capabilities and meeting demand for advanced device solutions across key care settings. The platform acquisition is a strategic acquisition by a strategic buyer, sized over $100M, and is currently announced with deal terms structured for up to $835M.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026